🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Guilin Sanjin Pharmaceutical Co., Ltd. (SHE:002275)
China flag China · Delayed Price · Currency is CNY
12.13
-0.38 (-3.04%)
Nov 20, 2026, 3:04 PM CST

SHE:002275 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
1,003990.991,0501,0581,2661,478
Short-Term Investments
---43.4--
Trading Asset Securities
572.93730.31626.15304.69161.24221.77
Cash & Short-Term Investments
1,5761,7211,6761,4061,4271,699
Cash Growth
-8.05%2.72%19.17%-1.45%-16.03%-2.47%
Accounts Receivable
354.79290.05527.3458.33542.51413.03
Other Receivables
76.0598.43118.064.3957.589.1
Receivables
430.84388.47645.36462.72600.09422.13
Inventory
209.26203.26208.29255.96244.9284.15
Other Current Assets
74.7350.8735.1871.1725.0648.4
Total Current Assets
2,2912,3642,5652,1962,2972,454
Property, Plant & Equipment
1,1001,1091,1111,1551,2271,313
Long-Term Investments
140.47532.94296.89299.09132.614.21
Goodwill
5.75.75.75.75.75.7
Other Intangible Assets
129.74134.81141.55153.56168.28178.36
Long-Term Deferred Tax Assets
6.687.1210.29.338.5311.35
Long-Term Deferred Charges
90.9596.16102.44117.04125.76128.8
Other Long-Term Assets
414.158.35---0.03
Total Assets
4,1794,2584,2323,9363,9654,096

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
162.1185.76191.55201.38133.92180.24
Accrued Expenses
17.88149.66184.85160.61160.45123.86
Short-Term Debt
35260.22325.26274.2140.01251.68
Current Portion of Long-Term Debt
88.2435.17103.3104.54107.5733.04
Current Portion of Leases
-10.8914.7214.7211.819.52
Current Income Taxes Payable
49.5512.5138.6325.9571.7938.13
Current Unearned Revenue
20.8798.2298.0675.99170.01132.79
Other Current Liabilities
114.3531.9539.1136.4551.3859.98
Total Current Liabilities
487.99784.39995.46893.83846.94829.23
Long-Term Debt
208.97180.91121.573.92128.03226.93
Long-Term Leases
23.9326.5928.8660.9578.4587.93
Long-Term Unearned Revenue
87.7970.2363.1589.0497.85111.22
Long-Term Deferred Tax Liabilities
000.15-0.330.73
Other Long-Term Liabilities
3.25.0513.321.34--
Total Liabilities
811.881,0671,2221,1191,1521,256

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
587.57587.57587.57587.57587.57590.2
Additional Paid-In Capital
672.09672.09672.09669.24638.76685.78
Retained Earnings
2,1261,8951,7811,5831,5731,767
Treasury Stock
------204
Comprehensive Income & Other
-19.0336.78-31.12-22.7214.130.64
Shareholders' Equity
3,3673,1913,0102,8172,8132,840
Total Liabilities & Equity
4,1794,2584,2323,9363,9654,096

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
356.14513.78593.63528.33465.88609.1
Net Cash (Debt)
1,2201,2081,082877.86961.071,090
Net Cash Growth
13.15%11.59%23.27%-8.66%-11.86%-18.50%
Net Cash Per Share
2.082.061.851.501.631.90
Filing Date Shares Outstanding
587.57587.57587.57587.57587.57575.27
Total Common Shares Outstanding
587.57587.57587.57587.57587.57575.27
Working Capital
1,8031,5801,5691,3021,4501,625
Book Value Per Share
5.735.435.124.794.794.94
Tangible Book Value
3,2313,0512,8632,6582,6392,656
Tangible Book Value Per Share
5.505.194.874.524.494.62
Buildings
-1,0621,000993.15997.121,053
Machinery
-799.56773.59775.0676.8676.54
Construction In Progress
-54.6969.5421.2461.66105.26